Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

There's no cure, but treatment for age-related macular degeneration (AMD) may slow the disease and keep you from having serious loss of vision.Dry macular degeneration is the most common type. It ...

Ohio State University. (2024, July 2). A new target for treatment of one type of macular degeneration. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 07 ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the market for age-related macular degeneration is ...

Can AI really replace scientists? Robin, an AI system, identified a potential drug for vision loss, but scientists are ...